iDR Conference Series

INTERNATIONAL DRUG REPURPOSING CONFERENCE

The iDR Conference Series is an annual global conference series where key opinion leaders from both the research and patient communities, funders, regulators and representatives from the private sector participate to collectively advance innovative drug repurposing in Europe and beyond.

NEXT iDR CONFERENCE:

Why join iDR?

Connect with global experts and key opinion leaders and learn first-hand why and how drug repurposing is fast evolving to revolutionise the medicine development landscape.

What to expect in iDR Conference Series?

Panel sessions

Keynote speakers

Lightening talks

Satellite meetings and workshops

Poster sessions

Exhibition booths

Networking activities

Discover benefits

Discover how patient communities, researchers, industry and health authorities can benefit from cutting-edge drug repurposing.

Explore innovative ideas

In collaboration with key stakeholders and experts, explore innovative ideas to remove major roadblocks.

Open discussions

Discuss the current drug repurposing landscape and the challenges its faced with.

Share knowledge

Become part of a wider community that works together and shares knowledge, experiences and best practices.

Who is it for?

PATIENTS

RESEARCHERS

INDUSTRY

FUNDERS

IMPACT INVESTORS

POLICY MAKERS & PAYERS

REGULATORY BODIES & HTA

RESEARCH INFRASTRUCTURE & SERVICE PROVIDERS

iDR24 Highlights

https://www.youtube.com/watch?v=km0SFrLI4R4
iDR24 Event Highlights

Why you shouldn’t miss the next iDR Conference

“Great crossing of disciplines, nations and continents.”

iDR24 attendee

“I realised that there is hope for repurposing, that there are plenty of scientists
and organisations that are working on it.”

iDR24 attendee

“Excellent overlook of best examples from methodology to repurposed drugs.”

iDR24 attendee

“It was great to hear other people's experiences with drug repurposing, learning
about regulatory challenges, and connecting to other people in the field.”

iDR24 attendee

“Very encouraging to see and learn about so many initiatives that share a similar
motivation, share similar issues to overcome barriers, and very much inspiring
to learn about concrete efforts to overcome or change these barriers.”

iDR24 attendee

Discover iDR24 here: all the articles, speakers and highlights

View highlights from

iDR24

Take a look at the highlights of the 2024 event.

Play Video

Insights from iDR24

Speakers

Listen to some of our key speakers of the 2024 event and their insights on the importance of the iDR Conference Series.

Play Video

Interested in becoming a sponsor of this event?

Showcase your business to a diverse audience, including researchers, the patient community, funders, regulators, and representatives from the private sector. As a sponsor, you'll get unique visibility through strategic logo placements, exhibition space, social media exposure, networking opportunities, and more. Contact our sponsorship team at sponsorship@remedi4all.org to find out more about the various sponsorship packages available.

Contact sponsorship team

Co-organisers

REMEDi4ALL

REMEDi4ALL is an EU-funded research initiative that is driving forward the repurposing of medicines in Europe.

Link to website
Beacon: For Rare Diseases (BEACON) - United Kingdom
Beacon for rare diseases

Beacon is a UK-based charity that is building a united rare disease community with patient groups at its heart.

Link to website

REMEDi4ALL Partners & Associated partners

Anticancer Fund (ACF) - Belgium
FIMM Institute for Molecular Medicine Finland
University of Helsinki
Istituto Ortopedico Rizzoli (IOR) - Italy
Bundesinstitut Fur Arzneimittel Und Medizinprodukte (BFARM) - Germany
Dompé farmaceutici Spa (DOMPÉ) – Italy
EATRIS (Coordinator) – The Netherlands
Fraunhofer-Gesellschaft – Germany
University Of Hull (UHULL) – United Kingdom
Istituto Di Ricerche Farmacologiche Mario Negri (IRFMN) - Italy
Karolinska Institutet (KI) - Sweden
The University Of Sheffield (USFD) - United Kingdom
Universitaetsmedizin Goettingen (UMG) - Germany
Uppsala Universitet (UU) - Sweden
Beacon: For Rare Diseases (BEACON) - United Kingdom
European Clinical Research Infrastructure Network (ECRIN) - France
European Organisation For Rare Diseases Association (EURORDIS) – France
Istituto Nazionale Tumori Fondazione Pascale (INT-NA) - Italy
Medicines For Europe (M4EU) - Belgium
Servicio Madrileño De Salud (SERMAS) - Spain
Syreon Kutato Intezet Korlatolt Felelossegu Tarsasag (SRI) - Hungary
Univerza V Ljubljani - Slovenia
ZonMw (Zorgonderzoek Nederland Zon) (ZONMW) - Netherlands

Don’t miss an update! Subscribe to the newsletter

Subscribe to the REMEDi4ALL newsletter to be the first to hear about iDR conference series news.